Addex Therapeutics Current Ratio Growth & History (ADXN)
Addex Therapeutics's current ratio was 1.40 for fiscal 2025.
View full Addex Therapeutics company overviewAddex Therapeutics annual current ratio history
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.40 | −3.01 | −68.26% |
| 2024 | 2024-12-31 | 4.42 | 2.95 | +201.66% |
| 2023 | 2023-12-31 | 1.46 | −0.92 | −38.64% |
| 2022 | 2022-12-31 | 2.39 | −2.92 | −55.05% |
| 2021 | 2021-12-31 | 5.31 | −0.08 | −1.42% |
| 2020 | 2020-12-31 | 5.38 | −0.32 | −5.59% |
| 2019 | 2019-12-31 | 5.70 | −12.36 | −68.43% |
| 2018 | 2018-12-31 | 18.06 | — | — |
Addex Therapeutics quarterly current ratio
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q2.23
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 0.97 | −2.05 | −67.83% |
| Q4 2025 | 2025-12-31 | 1.40 | −3.01 | −68.26% |
| Q3 2025 | 2025-09-30 | 2.01 | — | — |
| Q2 2025 | 2025-06-30 | 2.31 | — | — |
| Q1 2025 | 2025-03-31 | 3.03 | — | — |
| Q4 2024 | 2024-12-31 | 4.42 | 2.95 | +201.66% |
| Q4 2023 | 2023-12-31 | 1.46 | −0.92 | −38.64% |
| Q2 2023 | 2023-06-30 | 3.20 | — | — |
| Q4 2022 | 2022-12-31 | 2.39 | −2.92 | −55.05% |
| Q4 2021 | 2021-12-31 | 5.31 | −0.08 | −1.42% |
| Q4 2020 | 2020-12-31 | 5.38 | −0.32 | −5.59% |
| Q4 2019 | 2019-12-31 | 5.70 | −12.36 | −68.43% |
| Q4 2018 | 2018-12-31 | 18.06 | — | — |
Addex Therapeutics current ratio trends
Over the last five fiscal years, Addex Therapeutics's current ratio decreased from 5.38 to 1.40, a change of −3.98. The latest reported quarter, Q1 2026, shows 0.97.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Addex Therapeutics source filings ↗